Investment analysts at HC Wainwright initiated coverage on shares of Steadymed Ltd (NASDAQ:STDY) in a report issued on Monday. The firm set a “buy” rating and a $10.00 price target on the stock. HC Wainwright’s price objective would indicate a potential upside of 194.12% from the company’s current price.
Steadymed (NASDAQ:STDY) opened at 3.40 on Monday. The stock’s market cap is $68.47 million. The stock has a 50 day moving average of $3.70 and a 200-day moving average of $3.41. Steadymed has a one year low of $2.00 and a one year high of $5.21.
Steadymed Company Profile